Lysosomal enzyme release from human granulocytes is inhibited by indomethacin, ETYA, and BPB.
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology*; D000098:Acetophenones / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors; D003864:Depression, Chemical; D005089:Exocytosis / Q000187:drug effects; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D005966:Glucuronidase / Q000378:metabolism; D006098:Granulocytes / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D008247:Lysosomes / Q000201:enzymology; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D013481:Superoxides / Q000378:metabolism
D000098:Acetophenones; D016861:Cyclooxygenase Inhibitors; D005231:Fatty Acids, Unsaturated; D013481:Superoxides; D015117:5,8,11,14-Eicosatetraynoic Acid; D010741:Phospholipases A; D005966:Glucuronidase; C006821:4-bromophenacyl bromide; D001241:Aspirin; D007213:Indomethacin